Thyroid cancer and its associated factors: A population-based case-control study
- PMID: 33634859
- DOI: 10.1002/ijc.33537
Thyroid cancer and its associated factors: A population-based case-control study
Abstract
Considering the rising incidence and mortality of thyroid cancer (TC) worldwide, the aim of our study was to determine the risk factors for TC in a province with the highest incidence of TC in the country located at the South of Iran. A population-based case-control study was performed on 708 participants (361 new cases and 347 controls). The case participants were selected from the Iranian National Cancer Registry database. Frequency matched for gender and age, and the control participants were selected randomly from the neighborhood of the cases. Based on the results of multiple logistic regression analysis, benign thyroid diseases (eg, hyperthyroidism ORyes/no = 14.06, 95% CI: 5.13-38.51), family history of TC (ORyes/no = 3.54, 95% CI: 1.51-8.26), radiation exposure of the head (ORyes/no = 1.92, 95% CI: 1.03-3.60), family history of thyroid diseases (ORyes/no = 1.76, 95% CI: 1.19-2.62) and family history of other types of cancer (ORyes/no = 1.67, 95% CI: 1.01-2.74), significantly increased the risk of developing TC. On the other hand, high blood pressure (ORyes/no = 0.35, 95% CI: 0.19-0.64), higher education (ORcollege/illiterate = 0.54, 95% CI: 0.30-0.96), consumption of unsaturated fat (ORunsaturated/saturated = 0.59, 95% CI: 0.39-0.87) and being married (ORmarried/single = 0.60, 95% CI 0.37-0.98) were found to be protective factors. Some community-based interventions, for example, reduction in radiation exposure and screening members of families with underlying thyroid diseases may help in preventing or early diagnosis of TC. More studies on the health effects of local herbs are highly recommended.
Keywords: case-control study; risk factors; thyroid cancer.
© 2021 UICC.
Similar articles
-
Investigating papillary thyroid cancer risk factors among women living at the central region of Iran: a case-control study.BMC Endocr Disord. 2025 Jan 16;25(1):12. doi: 10.1186/s12902-025-01833-3. BMC Endocr Disord. 2025. PMID: 39819284 Free PMC article.
-
Lifestyle, dietary pattern and colorectal cancer: a case-control study.BMC Nutr. 2024 Oct 17;10(1):138. doi: 10.1186/s40795-024-00950-x. BMC Nutr. 2024. PMID: 39420424 Free PMC article.
-
Family history of malignant and benign thyroid diseases and risk of thyroid cancer: a population-based case-control study in New Caledonia.Cancer Causes Control. 2012 May;23(5):745-55. doi: 10.1007/s10552-012-9944-7. Epub 2012 Mar 29. Cancer Causes Control. 2012. PMID: 22456999 Clinical Trial.
-
Prevalence of thyroid diseases in familial adenomatous polyposis: a systematic review and meta-analysis.Fam Cancer. 2019 Jan;18(1):53-62. doi: 10.1007/s10689-018-0085-3. Fam Cancer. 2019. PMID: 29663106
-
The association of obesity with thyroid carcinoma risk.Cancer Med. 2022 Feb;11(4):1136-1144. doi: 10.1002/cam4.4498. Epub 2022 Jan 15. Cancer Med. 2022. PMID: 35032114 Free PMC article. Review.
Cited by
-
Unnecessity of Routine Dissection of Right Central Lymph Nodes in cN0 Papillary Thyroid Carcinoma Located at the Left Thyroid Lobe.Front Oncol. 2021 Jul 1;11:685708. doi: 10.3389/fonc.2021.685708. eCollection 2021. Front Oncol. 2021. PMID: 34277432 Free PMC article.
-
Iodine nutrition and papillary thyroid cancer.Front Nutr. 2022 Oct 20;9:1022650. doi: 10.3389/fnut.2022.1022650. eCollection 2022. Front Nutr. 2022. PMID: 36337631 Free PMC article. Review.
-
Thyroid Cancer: Epidemiology, Classification, Risk Factors, Diagnostic and Prognostic Markers, and Current Treatment Strategies.Int J Mol Sci. 2025 May 28;26(11):5173. doi: 10.3390/ijms26115173. Int J Mol Sci. 2025. PMID: 40507982 Free PMC article. Review.
-
Secular trends of morbidity and mortality of thyroid cancer in five Asian countries from 1990 to 2019 and their predictions to 2035.Thorac Cancer. 2023 Dec;14(36):3540-3548. doi: 10.1111/1759-7714.15160. Epub 2023 Nov 8. Thorac Cancer. 2023. PMID: 37941298 Free PMC article.
-
Family history of malignant or benign thyroid tumors: implications for surgical procedure management and disease-free survival.Front Endocrinol (Lausanne). 2023 Nov 29;14:1282088. doi: 10.3389/fendo.2023.1282088. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38093963 Free PMC article.
References
REFERENCES
-
- Kitahara CM, Kӧrmendiné Farkas D, Jørgensen JOL, Cronin-Fenton D, Sørensen HT. Benign thyroid diseases and risk of thyroid cancer: a nationwide cohort study. J Clin Endocrinol Metabol. 2018;103(6):2216-2224.
-
- Khodamoradi F, Ghoncheh M, Mehri A, Hassanipour S, Incidence SH. Mortality, and risk factors of thyroid cancer in the world: a review. World Cancer Res J. 2018;5(2):9.
-
- Wang Q, Huang H, Zhao N, Ni X, Udelsman R, Phytoestrogens ZY. Thyroid cancer risk: a population-based case-control study in Connecticut. Cancer Epidemiol Prev Biomarkers. 2020;29(2):500-508.
-
- Nguyen QT, Lee EJ, Huang MG, Park YI, Khullar A, Plodkowski RA. Diagnosis and treatment of patients with thyroid cancer. Am Health Drug Benefits. 2015;8(1):30-40.
-
- Prete A, de Souza PB, Censi S, Muzza M, Nucci N, Sponziello M. Update on fundamental mechanisms of thyroid cancer. Front Endocrinol. 2020;11:102.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical